X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5) 5
oncology (5) 5
humans (4) 4
adult (2) 2
aged (2) 2
aged, 80 and over (2) 2
cancer (2) 2
chemotherapy (2) 2
combination (2) 2
female (2) 2
immunohistochemistry (2) 2
middle aged (2) 2
neuroendocrine tumors - drug therapy (2) 2
neuroendocrine tumors - genetics (2) 2
neuroendocrine tumors - pathology (2) 2
phase-ii (2) 2
temozolomide (2) 2
adenocarcinoma (1) 1
advanced breast cancer (1) 1
animals (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antiemetics american society (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic agents, alkylating - pharmacology (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic agents, hormonal - therapeutic use (1) 1
aprepitant (1) 1
arousal (1) 1
bevacizumab (1) 1
biomarkers (1) 1
biomarkers, tumor (1) 1
biomedicine general (1) 1
body mass index (1) 1
breast neoplasms - complications (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - pathology (1) 1
c-kit (1) 1
carboplatin (1) 1
care and treatment (1) 1
chemotherapy-induced nausea (1) 1
chromogranin-a (1) 1
cinv (1) 1
clinical benefit (1) 1
colorectal cancer (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal neoplasms - pathology (1) 1
cystosarcoma-phyllodes (1) 1
dacarbazine - administration & dosage (1) 1
dacarbazine - analogs & derivatives (1) 1
dacarbazine - pharmacology (1) 1
dacarbazine - therapeutic use (1) 1
disease models, animal (1) 1
disease resistance (1) 1
double-blind (1) 1
emesis (1) 1
endocrine therapy (1) 1
estradiol - analogs & derivatives (1) 1
estradiol - therapeutic use (1) 1
everolimus (1) 1
expression (1) 1
follow-up (1) 1
fulvestrant (1) 1
gene expression regulation, neoplastic (1) 1
gene expression regulation, neoplastic - drug effects (1) 1
glioblastoma (1) 1
growth (1) 1
growth-factor receptor (1) 1
guideline update (1) 1
imatinib (1) 1
imatinib mesylate - pharmacology (1) 1
inflammation (1) 1
inhibition (1) 1
inhibitor (1) 1
interferon-alpha (1) 1
kinases (1) 1
lesions (1) 1
male (1) 1
males (1) 1
mast cells (1) 1
mast-cell degranulation (1) 1
medicine & public health (1) 1
metaanalysis (1) 1
metastases (1) 1
metastasis (1) 1
methylation (1) 1
mice (1) 1
mice, transgenic (1) 1
moderately emetogenic chemotherapy (1) 1
molecular targeted therapy (1) 1
mouse models (1) 1
mutations (1) 1
neoplasm metastasis (1) 1
neoplasm staging (1) 1
neuroendocrine tumor (1) 1
neuroendocrine tumors (1) 1
neuroendocrine tumors - metabolism (1) 1
neuron-specific enolase (1) 1
o-6-methylguanine dna methyltransferase (1) 1
obesity (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Cancer Therapeutics, ISSN 1535-7163, 02/2017, Volume 16, Issue 2, pp. 365 - 375
Prostate cancer is a leading cause of cancer-related death in males worldwide. Indeed, advanced and metastatic disease characterized by androgen resistance and... 
GROWTH-FACTOR RECEPTOR | CYSTOSARCOMA-PHYLLODES | TRANSGENIC ADENOCARCINOMA | ONCOLOGY | TYROSINE KINASE | C-KIT | PHASE-II | INHIBITOR | MAST-CELL DEGRANULATION | CANCER | MOUSE MODELS | Immunohistochemistry | Prostatic Neoplasms - metabolism | Seminal Vesicles - metabolism | Humans | Male | Proto-Oncogene Proteins c-kit - metabolism | Receptor, Platelet-Derived Growth Factor beta - genetics | Seminal Vesicles - pathology | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Prostatic Neoplasms - genetics | Female | Proto-Oncogene Proteins c-kit - genetics | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Prostatic Neoplasms - drug therapy | Disease Models, Animal | Receptor, Platelet-Derived Growth Factor beta - metabolism | Neuroendocrine Tumors - pathology | Prostatic Neoplasms - pathology | Imatinib Mesylate - pharmacology | Neuroendocrine Tumors - metabolism | Mice, Transgenic | Neuroendocrine Tumors - genetics | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Biomarkers | Neuroendocrine Tumors - drug therapy | Mice | Protein Kinase Inhibitors - pharmacology | Adenocarcinoma | Seminal vesicle | Metastasis | Males | Kinases | Metastases | Disease resistance | Signal transduction | Vesicles | Arousal | Protein-tyrosine kinase receptors | Inhibition | Lesions | Protein-tyrosine kinase | Tyrosine | Imatinib | Tumor cells | Pharmacology | Patients | Signaling | Mast cells | Prostate cancer | Prostate | Tumors | Cancer | Neuroendocrine tumors
Journal Article
Tumori, ISSN 0300-8916, 06/2019, Volume 105, Issue 3, pp. 253 - 258
To explore efficacy of short-course olanzapine with or without low-dose dexamethasone for prevention of delayed emesis in gynecologic cancer patients receiving... 
Carboplatin | CINV | olanzapine | emesis | palonosetron | ANTIEMETICS AMERICAN SOCIETY | GUIDELINE UPDATE | CHEMOTHERAPY-INDUCED NAUSEA | VOMITING CINV | APREPITANT | PROPHYLAXIS | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | DOUBLE-BLIND | RECEIVING PACLITAXEL | RADIOTHERAPY-INDUCED NAUSEA
Journal Article
Future Oncology, ISSN 1479-6694, 07/2015, Volume 11, Issue 13, pp. 1947 - 1959
Neuroendocrine neoplasms (NENs) are a group of heterogeneous tumors. The present review discusses current therapeutic strategies for the treatment of... 
PRRT | neuroendocrine tumor | somatostatin analogs | chemotherapy | target therapy | PROGNOSTIC-FACTORS | EVEROLIMUS | BEVACIZUMAB | TUMOR RESPONSE | CHROMOGRANIN-A | COMBINATION | TEMOZOLOMIDE | INTERFERON-ALPHA | PLUS OCTREOTIDE | ONCOLOGY | NEURON-SPECIFIC ENOLASE
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.